Drug intelligence / Profile preview

An'erdian

Development stage
Unknown
Lead developer
Shanghai Likang Disinfectant High-Tech
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

An'erdian is a topical skin antiseptic formulated for rapid and long-lasting antibacterial, yeasticidal, fungicidal, and virucidal effects. It contains available iodine (0.2%), chlorhexidine acetate (0.45%), and ethanol (65%) as active ingredients. The product is dermatologically tested, hypoallergenic, non-irritating, perfume-free, and effective against a broad spectrum of pathogens including bacteria, yeast, fungi, and viruses such as HBV, HIV, HCV, Herpes simplex virus, and Influenza virus. It is intended for preoperative skin preparation or disinfection at the site of operation or injection[5].

Brand names
An'erdian
Other names
Ana erdian Skin Antiseptic
02

Targets

Microbial cell membrane lipids and membrane-associated proteins

Beyond the preview

Go deeper on An'erdian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on An'erdian.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call